
Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk
Author(s) -
Xuemin Liang,
Xiaoping Fan,
Kanglian Tan,
Li Zhang,
Lisi Jian,
Linchong Yu
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.235346
Subject(s) - odds ratio , medicine , confidence interval , colorectal cancer , gastroenterology , subgroup analysis , population , oncology , cancer , environmental health
Several studies evaluated the association between peroxisome proliferators-activated receptor gamma (PPARγ) Pro12Ala (rs1801282), and His477His (rs3856806) polymorphisms and the risk of colorectal cancer (CRC). However, the results were not stable.